Table 3.
The Clinical Data of Men T2DM Patients Were Compared Between the Two Groups
| Sarcopenia Group (n=66) | Non-Sarcopenia Group (n=94) | Z/t value | P value | |
|---|---|---|---|---|
| Age (y) | 67.97±5.74 | 67.55±5.39 | 0.468 | 0.640 |
| Course of disease (y) | 10 (6, 18) | 10 (6, 19) | 0.322 | 0.747 |
| BMI (kg/m2) | 22.69±2.23 | 26.03±2.67 | 8.346 | < 0.001 |
| SBP (mmHg) | 134.11±19.00 | 136.54±16.73 | 0.857 | 0.393 |
| DBP (mmHg) | 74.27±10.21 | 75.77±11.09 | 0.866 | 0.388 |
| FBG (mmo/l) | 8.08±3.25 | 8.02±2.70 | 0.127 | 0.899 |
| HbA1c (%) | 9.02±1.98 | 8.70±1.79 | 1.075 | 0.284 |
| Hb (g/l) | 130.97±20.98 | 136.35±20.25 | 1.630 | 0.105 |
| Alb (g/l) | 37.64±5.54 | 38.86±4.06 | 1.611 | 0.109 |
| TG (mmol/l) | 1.2 (0.85, 1.71) | 1.425 (0.915, 1.74) | 1.160 | 0.246 |
| TCH (mmol/l) | 4.32±1.03 | 4.16±1.17 | 0.880 | 0.380 |
| LDL-C (mmol/l) | 2.7±0.85 | 2.55±0.84 | 1.105 | 0.271 |
| HDL (mmol/l) | 1.15±0.27 | 1.06±0.27 | 2.084 | 0.039 |
| SCr (umol/l) | 88.59±40.21 | 80.1±24.8 | 1.525 | 0.130 |
| eGFR [mL/(min · 1.73m2)] | 80.69±22.79 | 85±17.96 | 1.335 | 0.184 |
| UA (umol/l) | 330.61±94.49 | 330±77.63 | 0.044 | 0.965 |
| Urine ACR (mg/g) | 17.28 (11.78, 41.25) | 20.94 (13.25, 70.62) | 0.842 | 0.400 |
| 25(OH)D (ng/mL) | 27.49±7.57 | 30.86±8.07 | 2.671 | 0.008 |
| GH (ng/mL) | 2.11 (1.00, 2.78) | 2.29 (0.61, 2.77) | 0.052 | 0.959 |
| IGF-1 (ng/mL) | 145.69±40.1 | 163.79±39.98 | 2.816 | 0.005 |
| Testosterone (ng/dl) | 353.05±127.24 | 448.93±166.84 | 3.933 | < 0.001 |